OncoPep, Inc.
www.oncopep.comThrough targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell focused technologies are designed to be used on their own or in combination with other immunotherapeutics.
Read more
Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell focused technologies are designed to be used on their own or in combination with other immunotherapeutics.
Read more
Country
State
Massachusetts
City (Headquarters)
Boston
Industry
Employees
11-50
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Medical Officer
Email ****** @****.comPhone (***) ****-****Chief Strategy Officer ( Chief Security Officer )
Email ****** @****.comPhone (***) ****-****Senior Staff Accountant
Email ****** @****.comPhone (***) ****-****Scientist ( Immuno - Oncology )
Email ****** @****.comPhone (***) ****-****
Technologies
(33)
Reach decision makers at OncoPep, Inc.
Free credits every month!
OncoPep, Inc. FAQ
Boston, United States
Biotechnology Research
